Home

Betapapillomavirus

Betapapillomavirus is a genus of papillomaviruses within the family Papillomaviridae. Betapapillomaviruses (beta-HPV) primarily infect the skin of humans and are one of several genera that cause human papillomavirus infections. More than a dozen beta types have been described, with HPV-5 and HPV-8 among the best studied; types are genetically related but type-specific.

Genome and biology: Beta-HPVs are non-enveloped icosahedral viruses with circular double-stranded DNA genomes of roughly 8

Clinical features and disease associations: Most infections are asymptomatic or result in minor cutaneous warts. In

Diagnosis and prevention: Diagnosis is through detection and typing of HPV DNA from skin lesions. There are

Taxonomy: Betapapillomavirus is one genus within Papillomaviridae, comprising multiple species and numerous types. The taxonomy is

kilobases.
They
encode
early
genes
E1,
E2,
E6,
E7,
sometimes
E5,
and
late
genes
L1
and
L2.
The
infection
targets
basal
keratinocytes
in
the
epidermis;
replication
occurs
as
infected
cells
differentiate,
with
late
genes
expressed
in
suprabasal
layers.
The
viruses
establish
long-term
colonization
of
skin
and
typically
cause
no
overt
disease
in
most
individuals.
people
with
epidermodysplasia
verruciformis
(EV)
or
in
severely
immunocompromised
individuals,
beta-HPV
infection
can
lead
to
widespread
flat
warts
and
has
been
linked
to
an
increased
risk
of
non-melanoma
skin
cancer,
particularly
when
combined
with
ultraviolet
light
exposure.
The
precise
role
of
beta-HPV
in
sporadic
skin
cancers
remains
uncertain;
evidence
suggests
it
may
act
as
a
cofactor
rather
than
a
primary
cause.
Serology
is
unreliable
for
diagnosis;
detection
relies
on
molecular
methods
such
as
PCR.
no
licensed
vaccines
targeting
beta-HPV
types;
current
HPV
vaccines
protect
against
several
alpha-HPV
types
associated
with
mucosal
cancers
and
warts.
Research
into
multivalent
vaccines
aims
to
broaden
protection
against
cutaneous
HPV
types.
Management
of
beta-HPV
infections
focuses
on
treating
lesions
and
monitoring
skin
cancers
in
high-risk
individuals.
under
ongoing
refinement.